FeelGood vs SkinnyRx: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

SkinnyRx beats FeelGood overall, scoring 7.3/10 vs 7/10. FeelGood is more affordable at $149/mo vs $199/mo. Choose FeelGood for budget-conscious cash-pay patients who want low-cost compoun. Choose SkinnyRx for users who want flexibility in compounded glp-1 medication fo.

A side-by-side comparison of FeelGood and SkinnyRx covering pricing, scores, medication types, insurance, and more to help you decide.

FeelGood

#48 of 49

7/10

Telehealth platform offering compounded semaglutide as both a weekly injection ($149/mo starting) and a daily oral tablet ($249/mo starting), plus a premium brand-name 'original' semaglutide injection option ($1,999/mo). Cash-pay only, no insurance billing, HSA/FSA eligible. LegitScript-approved. FeelGood does not publicly disclose which states it serves, its compounding pharmacy, or its medical leadership.

Visit FeelGood

Higher Rated

SkinnyRx

#36 of 49

7.3/10

Direct-to-consumer telehealth platform offering compounded GLP-1 medications across five formats — injectable and sublingual semaglutide, semaglutide tablets, and tirzepatide as either injectable or tablets. Operated by Lean Rx, Inc. (Sacramento, CA). Compounded only — does not prescribe brand-name Wegovy/Zepbound/Ozempic/Mounjaro. Cash-pay only with HSA/FSA accepted; does not bill insurance. 4,100+ Trustpilot reviews at 4.8 stars.

Visit SkinnyRx

Feature	FeelGood	SkinnyRx
Our Score	7/10	7.3/10
Starting Price	$149/mo	$199/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee	Users who want flexibility in compounded GLP-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point
Ranking	#48	#36

Pros & Cons Compared

FeelGood

Pros

+Compounded semaglutide injection from $149/mo with free shipping and no separate membership or consultation fee
+Offers an oral compounded semaglutide tablet ($249/mo) for needle-averse patients — a non-injectable route only a handful of platforms provide
+LegitScript-approved — independent certification that the telehealth/pharmacy operation meets legal and safety standards, which many budget compounded shops lack
+Money-back weight-loss guarantee plus unlimited 24/7 messaging and appointments included

Cons

−Does NOT publicly disclose which US states it serves — you can't confirm availability in your state before starting an intake
−$149 is a 'starting' price (dose-escalating), not flat across all doses — your cost can rise as your dose titrates up, and FeelGood doesn't publish the full dose-by-dose schedule
−Brand-name 'original' semaglutide injection at $1,999/mo is far above market — NovoCare direct Wegovy is $349/mo and Hers offers Wegovy at $149/mo via the 2026 Novo Nordisk partnership. Never buy brand-name through FeelGood
−No named medical director, prescribing physicians, compounding pharmacy, founding year, or headquarters disclosed on the site — thin corporate and clinical transparency
−Self-reported '4.8/5' rating is not tied to a named third-party platform (no linked Trustpilot/BBB), so it can't be independently verified; the advertised '15–20% weight loss' figures are FeelGood's marketing, not FDA-reviewed efficacy data
−Compounded GLP-1s are not FDA-approved (none are) — and FeelGood offers compounded semaglutide only, no tirzepatide

SkinnyRx

Pros

+Five medication formats — the broadest compounded-GLP-1 menu in DTC telehealth, including the rare oral tirzepatide tablet that almost no competitor offers
+$199/mo entry price for both injectable and sublingual semaglutide is competitive in the mid-tier compounded segment
+Fast onboarding: 5–10 minute online questionnaire, physician review in 24–48 hours, medication delivered in 3–7 business days with temperature-controlled shipping
+4,100+ Trustpilot reviews at 4.8 stars — among the strongest aggregate social-proof signals in the GLP-1 telehealth category

Cons

−No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded-only model limits patients who want or need an FDA-approved finished product
−Limited public transparency: founders, executive team, medical director, and specific compounding-pharmacy partners are not named on the public site
−Cash-pay only — does not bill commercial insurance, Medicare, or Medicaid (HSA/FSA payments accepted)
−Independent reviews flag inconsistent customer-service responsiveness, which is a real concern for a medication that requires titration support and dose-adjustment dialogue

Our Verdict

SkinnyRx edges out FeelGood with a score of 7.3/10 vs 7/10. If budget is your priority, FeelGood starts at $149/mo compared to SkinnyRx's $199/mo. FeelGood offers both brand-name and compounded medications, giving you more flexibility. Choose FeelGood if you want: budget-conscious cash-pay patients who want low-cost compounded semaglutide — injection or oral tablet — with free shipping, no membership fees, and a money-back weight-loss guarantee. Choose SkinnyRx if you want: users who want flexibility in compounded glp-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither FeelGood nor SkinnyRx feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review